Skip to content

Drug interactions

Belimumab + Fingolimod

Severity: Moderate

Belimumab and Fingolimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Belimumab inhibits B-cell survival and fingolimod reduces circulating lymphocytes, so the combination may increase infection risk. Clinical data on combined use are limited.

What this interaction means in plain words

Belimumab and Fingolimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Belimumab belongs to Miscellaneous; Fingolimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive immunosuppression via BLyS inhibition and lymphocyte sequestration.

What to do

Monitor for infection and lymphocyte counts if used together, and reassess the need for both agents.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Belimumab and Fingolimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Belimumab with Fingolimod?

MediHelp rates the interaction as moderate. Belimumab and Fingolimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Belimumab inhibits B-cell survival and fingolimod reduces circulating lymphocytes, so the combination may increase infection risk. Clinical data on combined use are limited.

How serious is the interaction between Belimumab and Fingolimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and lymphocyte counts if used together, and reassess the need for both agents.

What other medicines interact with Fingolimod?

MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in